Inventor · disambiguated record
Tomasz Cierpicki
Also filed as: CIERPICKI TOMASZ
28 granted patents·6 pending applications·207 citations·filing 2010–2025
96Inventor score
Top patents by PatentIndex Score
34 records- 0196US11673898B2Substituted inhibitors of menin-MLL and methods of useKURA ONCOLOGY INC·Filed 2020·Granted Jun 13, 2023·6 cites·27 claims
- 0296US10781218B2Substituted inhibitors of menin-MLL and methods of useKURA ONCOLOGY INC·Filed 2017·Granted Sep 22, 2020·16 cites·20 claims
- 0396US10077271B2Methods and compositions for inhibiting the interaction of menin with MLL proteinsKURA ONCOLOGY INC·Filed 2017·Granted Sep 18, 2018·14 cites·18 claims
- 0495US11147885B2ASH1L inhibitors and methods of treatment therewithUNIV MICHIGAN REGENTS·Filed 2020·Granted Oct 19, 2021·5 cites·20 claims
- 0595US9216993B2Compositions comprising thienopyrimidine and thienopyridine compounds and methods of use thereofUNIV MICHIGAN·Filed 2014·Granted Dec 22, 2015·33 cites·54 claims
- 0694US10632209B2ASH1L inhibitors and methods of treatment therewithUNIV MICHIGAN REGENTS·Filed 2018·Granted Apr 28, 2020·9 cites·18 claims
- 0794US9505781B2Compositions comprising thienopyrimidine and thienopyridine compounds and methods of use thereofUNIV MICHIGAN REGENTS·Filed 2014·Granted Nov 29, 2016·16 cites·50 claims
- 0894US9505782B2Compositions comprising thienopyrimidine and thienopyridine compounds and methods of use thereofUNIV MICHIGAN REGENTS·Filed 2015·Granted Nov 29, 2016·24 cites·26 claims
- 0993US10752639B2Bridged bicyclic inhibitors of menin-MLL and methods of useKURA ONCOLOGY INC·Filed 2017·Granted Aug 25, 2020·8 cites·14 claims
- 1092US10588907B2Methods and compositions for inhibiting the interaction of menin with MLL proteinsKURA ONCOLOGY INC·Filed 2016·Granted Mar 17, 2020·6 cites·1 claims
- 1192US10174041B2Methods and compositions for inhibiting the interaction of menin with MLL proteinsKURA ONCOLOGY INC·Filed 2018·Granted Jan 8, 2019·11 cites·24 claims
- 1292US10160769B2Compositions comprising thienopyrimidine and thienopyridine compounds and methods of use thereofUNIV MICHIGAN REGENTS·Filed 2016·Granted Dec 25, 2018·10 cites·25 claims
- 1390US9212180B2Menin-MLL inhibitors and methods of use thereofUNIV MICHIGAN·Filed 2014·Granted Dec 15, 2015·11 cites·19 claims
- 1489US11833210B2ASH1L inhibitors and methods of treatment therewithUNIV MICHIGAN REGENTS·Filed 2021·Granted Dec 5, 2023·1 cites·19 claims
- 1589US11786602B2ASH1L degraders and methods of treatment therewithUNIV MICHIGAN REGENTS·Filed 2021·Granted Oct 17, 2023·1 cites·20 claims
- 1689US10246464B2Thienopyrimidine and thienopyridine compounds and methods of use thereofUNIV MICHIGAN REGENTS·Filed 2015·Granted Apr 2, 2019·9 cites·20 claims
- 1788US11542248B2Methods and compositions for inhibiting the interaction of menin with MLL proteinsKURA ONCOLOGY INC·Filed 2018·Granted Jan 3, 2023·4 cites·14 claims
- 1887US11110177B2ASH1L degraders and methods of treatment therewithUNIV MICHIGAN REGENTS·Filed 2018·Granted Sep 7, 2021·2 cites·16 claims
- 1986US8993552B2Compositions and methods for treatment of leukemiaGREMBECKA JOLANTA·Filed 2010·Granted Mar 31, 2015·17 cites·10 claims
- 2085US12285490B2ASH1L degraders and methods of treatment therewithUNIV MICHIGAN REGENTS·Filed 2023·Granted Apr 29, 2025·0 cites·19 claims
- 2184US11555041B2Bridged bicyclic inhibitors of menin-MLL and methods of useKURA ONCOLOGY INC·Filed 2020·Granted Jan 17, 2023·1 cites·10 claims
- 2277US11319302B2PRC1 inhibitors and methods of treatment therewithUNIV MICHIGAN REGENTS·Filed 2019·Granted May 3, 2022·2 cites·13 claims
- 2371US2025339406A1Nsd family inhibitors and methods of treatment therewithUNIV MICHIGAN REGENTS·Filed 2025·Application pending·0 cites
- 2470USRE49687EThienopyrimidine and thienopyridine compounds and methods of use thereofUNIV MICHIGAN REGENTS·Filed 2015·Granted Oct 10, 2023·1 cites·25 claims
- 2568US2025304589A1Methods and compositions for inhibiting the interaction of menin with mll proteinsKURA ONCOLOGY INC·Filed 2025·Application pending·0 cites
- 2667US2025320225A1Substituted inhibitors of menin-mll and methods of useKURA ONCOLOGY INC·Filed 2025·Application pending·0 cites
- 2766US12364688B2NSD family inhibitors and methods of treatment therewithUNIV MICHIGAN REGENTS·Filed 2022·Granted Jul 22, 2025·0 cites·3 claims
- 2866US2025340566A1Bridged bicyclic inhibitors of menin-mll and methods of useKURA ONCOLOGY INC·Filed 2025·Application pending·0 cites
- 2964US2024245645A1Ash1l inhibitors and methods and treatment therewithUNIV MICHIGAN REGENTS·Filed 2024·Application pending·0 cites
- 3063US12466813B2PRC1 inhibitors and methods of treatment therewithUNIV MICHIGAN REGENTS·Filed 2022·Granted Nov 11, 2025·0 cites·7 claims
- 3157US11324729B2NSD family inhibitors and methods of treatment therewithUNIV MICHIGAN REGENTS·Filed 2018·Granted May 10, 2022·0 cites·6 claims
- 3251US11883381B2ASH1L inhibitors and methods of treatment therewithUNIV MICHIGAN REGENTS·Filed 2017·Granted Jan 30, 2024·0 cites·13 claims
- 3345US11858925B2GAS41 inhibitors and methods of use thereofUNIV MICHIGAN REGENTS·Filed 2021·Granted Jan 2, 2024·0 cites·15 claims
- 3440US2016045504A1Compositions and methods for treatment of leukemiaUNIV MICHIGAN·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Tomasz Cierpicki files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →